Back
Structure Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
40
GPCR
Structure Therapeutics
Last Price:
39.32
Seasonality Move:
-35.87%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.92 | Buy |
| 20-day SMA: | 38.87 | Buy |
| 50-day SMA: | 39.6 | Buy |
| 200-day SMA: | 40.28 | Sell |
| 8-day EMA: | 39.45 | Buy |
| 20-day EMA: | 39.31 | Buy |
| 50-day EMA: | 39.42 | Buy |
| 200-day EMA: | 39.73 | Buy |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 51.34 | Buy |
| Chaikin Money Flow: | -625102 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.61 - 41.77) | Buy |
| Bollinger Bands (100): | (36.09 - 43.17) | Buy |
Structure Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 39.74 while GPCR 8-day simple moving average is 38.92, which is a Buy signal.
- The stock price of GPCR is 39.74 while Structure Therapeutics 20-day SMA is 38.87, which makes it a Buy.
- Structure Therapeutics 50-day simple moving average is 39.60 while GPCR share price is 39.74, making it a Buy technically.
- GPCR stock price is 39.74 and Structure Therapeutics 200-day simple moving average is 40.28, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
40
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Sell
The current Structure Therapeutics [GPCR] share price is $39.74. The Score for GPCR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
2.27B
Price in USD:
39.74
Share Volume:
823.73K
Structure Therapeutics 52-Week Range
52-Week High:
72.16
52-Week Low:
26.61
Sell
40
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 39.74 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 39.74 while GPCR 8-day exponential moving average is 39.45, which is a Buy signal.
- The stock price of GPCR is 39.74 while Structure Therapeutics 20-day EMA is 39.31, which makes it a Buy.
- Structure Therapeutics 50-day exponential moving average is 39.42 while GPCR share price is 39.74, making it a Buy technically.
- GPCR stock price is 39.74 and Structure Therapeutics 200-day simple moving average is 39.73, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting Structure Therapeutics is a Sell
- Structure Therapeutics Relative Strength Index (RSI) is 51.34, which suggest Structure Therapeutics is overbought
- The Bollinger Bands (25) for Structure Therapeutics is (37.61 - 41.77), which suggest Structure Therapeutics is a Buy
- The Bollinger Bands (100) for Structure Therapeutics is (36.09 - 43.17), which suggest Structure Therapeutics is a Buy
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.